Overview

A Comparison of Emtricitabine and Stavudine Used With Didanosine Plus Efavirenz in HIV-Infected Patients Who Have Not Taken Anti-HIV Drugs

Status:
Unknown status

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Summary

The purpose of this study is to compare the safety and effectiveness of emtricitabine and stavudine when given with didanosine plus efavirenz to HIV-infected patients.

Phase:

Phase 3

Details

Lead Sponsor:

Triangle Pharmaceuticals

Treatments:

Didanosine
Efavirenz
Emtricitabine
Stavudine